Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Biochem Soc Trans. 2012 Jun 1;40(3):561–566. doi: 10.1042/BST20120067

Engineering oxidoreductases: maquette proteins designed from scratch

Bruce R Lichtenstein *,1, Tammer A Farid *, Goutham Kodali *, Lee A Solomon *, JL Ross Anderson , Molly M Sheehan *, Nathan M Ennist *, Bryan A Fry *, Sarah E Chobot , Chris Bialas *, Joshua A Mancini *, Craig T Armstrong , Zhenyu Zhao *, Tatiana V Esipova *, David Snell §, Sergei A Vinogradov *, Bohdana M Discher *, Christopher C Moser *, P Leslie Dutton *
PMCID: PMC3525474  NIHMSID: NIHMS425300  PMID: 22616867

Abstract

The study of natural enzymes is complicated by the fact that only the most recent evolutionary progression can be observed. In particular, natural oxidoreductases stand out as profoundly complex proteins in which the molecular roots of function, structure and biological integration are collectively intertwined and individually obscured. In the present paper, we describe our experimental approach that removes many of these often bewildering complexities to identify in simple terms the necessary and sufficient requirements for oxidoreductase function. Ours is a synthetic biology approach that focuses on from-scratch construction of protein maquettes designed principally to promote or suppress biologically relevant oxidations and reductions. The approach avoids mimicry and divorces the commonly made and almost certainly false ascription of atomistically detailed functionally unique roles to a particular protein primary sequence, to gain a new freedom to explore protein-based enzyme function. Maquette design and construction methods make use of iterative steps, retraceable when necessary, to successfully develop a protein family of sturdy and versatile single-chain three- and four-α-helical structural platforms readily expressible in bacteria. Internally, they prove malleable enough to incorporate in prescribed positions most natural redox cofactors and many more simplified synthetic analogues. External polarity, charge-patterning and chemical linkers direct maquettes to functional assembly in membranes, on nanostructured titania, and to organize on selected planar surfaces and materials. These protein maquettes engage in light harvesting and energy transfer, in photochemical charge separation and electron transfer, in stable dioxygen binding and in simple oxidative chemistry that is the basis of multi-electron oxidative and reductive catalysis.

Keywords: electron transfer, maquette, oxidoreductase, protein design, protein engineering, synthetic protein

Introduction

All too commonly, it is inferred that a specific biochemical function is necessarily linked with either a singular enzyme structure or a particular primary sequence. This ignores the apparent ‘memory-less’ random Markovian process of evolution that occurs down to the codon level [1]. An unknown and probably large variety of evolutionary pressures have contributed to the selection of the observed primary sequence and molecular structure, obfuscating and overlapping the multiplicity of biological roles that each amino acid plays [2,3]. These facts impair broad scientific goals directed at understanding and exploiting the fundamental principles and requirements for effective biological activity of natural enzymes. In some tantalizing cases, functionally identical enzymes from a variety of biological sources preserve ‘active-site’ residues; however, these residues may only afford the observed catalytic activity within their particular structural contexts. This makes it all but impossible to infer that those same residues placed appropriately will definitely yield the same function in some other protein structural family.

A practical understanding of the engineering of natural proteins relies on identifying the key structural and energetic terms naturally selected to carry out each specific enzymatic mechanism, as well as the quantification of the level of activity sufficient for adequate functional performance in an organism. In the absence of this information, it is understandable that researchers have assumed all things important and focused upon atomistic descriptions long thought to be essential for describing mechanistic detail. Unfortunately, leaps from this level of detail out to broader discussions of evolved activities take place without full knowledge of what, in Darwinian terms, natural selection acted upon, thereby limiting the scope of mechanistic conclusions.

Advances in rational protein design and engineering have allowed inferences gathered from bioinformatics studies of enzyme families to be tested directly [49]. This is particularly apparent in the growing literature of enzymes with substrate specificity rationally altered, usually by changing active-site loops [10,11]. Beyond substrate recognition and enzymatically competent binding, much recent progress has been made in wholescale modification or generation of catalytic activity in protein scaffolds [1214]. The Baker group has led the way in producing enzymatic function built into natural scaffolds, including the creation of enzymes capable of catalysing reactions not known to occur naturally [15,16]. These experiments use a computational approach called Rosetta [17,18] and serve as a significant demonstration of our knowledge of both protein design and enzymatic mechanisms. Yet even with these remarkable successes, there remain open questions as to both the necessity of the computationally selected active-site residues and choice in protein scaffold, as well as the need for a computational approach at all in designing similar activity. The recapitulation of the novel Kempelimination enzymatic of a computationally redesigned protein [15] in a hand-redesigned variant of calmodulin [19] suggests that computational design is neither necessary for or uniquely capable of generating proteins with new non-natural activities.

Some of the major challenges in protein engineering are the creation of binding sites for small-molecule ligands and the tight stable binding of cofactors. Not surprisingly, there is less work on the rational design of novel oxidoreductase functions, which depend almost exclusively upon cofactor incorporation into protein scaffolds. Whereas some groups have succeeded in modifying natural oxidoreductases to accomplish additional desirable activities [20], insights into the fundamental requirements for the targeted function are obscured by the native biological function and role of the chosen scaffolds themselves. Our synthetic biology approach to creating and exploring oxidoreductase function divorces designed activities from naturally occurring scaffolds, and constructs protein maquettes from scratch.

The maquette method

Defined as a non-complex functional protein scaffold, maquettes were born out of the need to cut through the frustrating complexity of natural oxidoreductases [21]. Study of natural oxidoreductases, especially those within the membranes of mitochondria and chloroplasts, is complicated by the many cryptic and overlapping spectral features of the various cofactors involved. Common biochemical techniques such as observing the effects of site-directed mutagenesis are blunted by this complexity and have left some of the salient features of their function undiscovered. Natural biological roles of these proteins add to their complexity, so studying oxidoreductase function specifically demands an approach that divests study from that biology.

Maquettes use established engineering parameters to generate simple non-natural four-α-helix bundles [22] (Figure 1), and build basic oxidoreductase activities into these scaffolds to allow us to understand and explore the engineering parameters of natural oxidoreductases [23]. The four-α-helix bundle was chosen as the scaffold form because its engineering principles are the most well defined of the self-contained tertiary structures. Functions were added by adjusting critical residues needed to bind to redox-active moieties. The combination of the established architecture and the relative ease at mutating these residues led to a rapid expansion in the nature of oxidoreductase function available for exploration in the maquettes. Indeed, iron and zinc tetrapyroles, iron–sulfur clusters, di-metal centres, flavins, quinones and nicotinamide have all been established in non-natural four-α-helix bundles ([2431], and B.R. Lichtenstein and D. Snell, unpublished work) (Figure 2).

Figure 1. Maquette design, based on α-helical bundles, follows the principle of binary patterning.

Figure 1

The specific topological assembly of the α-helices is controlled principally by connecting loops. Topological labels refer to sequences in Figure 4, and include both hydrophilic (A–E and G) and amphiphilic (F) maquettes. Cofactors such as tetrapyrroles (blue) are placed at selected positions along the bundle.

Figure 2.

Figure 2

Common biological redox cofactors and related novel cofactors incorporated into maquettes

Although it is clear that cofactor binding of one form or another is a critical feature of the maquettes, our proteins are more than cofactor scaffolds and provide an excellent structural basis for more advanced oxidoreductase function such as charge separation and catalysis. Present maquette functions include redox-dependent conformational switching [32], molecular oxygen binding [33] and quinol–cytochrome c oxidoreductase activity [34]. Given the design versatility of the maquettes, we have come to view them as molecular laboratories and to establish each new design as one would an experimental set-up. We also believe that the approach is of a broader value to the scientific community and, in the present paper, seek to introduce our three-step process for maquette development.

Maquette step 1: choose function

As with other rational protein design approaches, an initial selection of function guides every design choice that follows. We define function as an activity, covering everything from adopting a desired secondary structure to cofactor binding to catalysis. Development of a maquette begins with a clear sense of a fundamental target function. These keystone functions will often serve as the basis for more advanced functions; for instance, oxidoreductase activity may require that a cofactor be bound, and this cofactor binding serves as a keystone function. Early maquettes focused almost exclusively on simple redox function imparted upon them by a bonded cofactor, yet additional functions such as native-like fold and molecular oxygen binding were also pursued. Each selected function serves as a constraint to design parameters that are guided by observations of Nature.

Maquette step 2: obtain engineering from observing Nature

The maquette scaffold, most commonly four-α-helix bundles, is the first engineering parameter considered. We have focused on incorporating oxidoreductase functions in four-α-helix bundles because this structure has well-established engineering requirements. Regan and DeGrado [22] demonstrated that peptides with polar and non-polar residues properly patterned around a heptad repeat would spontaneously assemble into soluble four-α-helical bundles. This so-called ‘binary patterning’ drives the bundle assemblies to form due to partitioning of hydrophobic residues into the protein core and polar residues on to the surface.

By starting with a well-defined scaffold with known engineering requirements, we are constrained in our placement of residues for keystone function and therefore guided in the selection of design criteria for additional functions. This constraint greatly simplifies matters and opens the way to a manual design process. In particular, residues essential for keystone functions are the first to be placed in the starting bundle sequence. Importantly to our work, cofactor number, placement, orientation, identity and anticipated redox potential are the most common design parameters that arise from chosen functions. The basic ligation residues and cofactor choices are usually the only design aspects taken directly from Nature and consist of a minimal part of the maquette sequence, as little as one residue.

The number and placement of cofactors is often guided by additional parameters obtained from our work defining empirical expressions describing electron transfer kinetics [35] (Figure 3). These expressions, derived from a semi-classical theory of electron transfer and parameterized by observation of events in natural oxidoreductases, serves to constrain the number and placement of cofactors and thus the residues necessary for their incorporation. The heptad repeating unit of the helix quantizes this selection parameter further, as not all cofactor distances are available in a four-α-helix bundle.

Figure 3. Electron-transfer reactions can be designed using parameters gleaned from natural engineering.

Figure 3

Designing artificial electron-transfer proteins takes advantage of the observation that single-electron-transfer reactions in proteins occur by means of electron tunnelling with characteristic rates that depend on three adjustable parameters: distance, driving force and reorganization energy. This driving force and distance contour plot is illustrated with a typical reorganization energy of 0.9 eV.

Subsequent sequence changes come about from additional constrains brought about by the choice of function. For instance, the iterative development of an oxygen-binding maquette involved the enhancement of the hydrophobicity of a haem-binding site followed by the introduction of buried charged residues to induce strain on the bis-histidine haem ligation [33,36]. Parameters such as these also arise from understanding the physical needs for function that are demonstrated in natural proteins. More than just mimicry, these considerations define a real set of engineering principles that can further guide design criteria for maquettes.

Before sequences are synthesized or expressed, some amount of manual sequence pruning is attempted to reduce steric clashes, poor geometries and incompatible charge–charge interactions; these steps are often aided by simple molecular modelling to assist in shape matching. Because the maquettes are not constructed from natural scaffolds, after the sequences have been finalized, we have the ability to reconcile the rationale for the selection of each amino acid throughout the design [21]. This greatly enhances our ability to properly assess and quantitatively ascribe to every amino acid its role in each observed maquette function, an understanding out of reach in complex natural proteins.

Maquette step 3: iterate

Unlike most other rational protein design methods, our approach makes explicit use of experimental characterization of each newly created maquette in the design process. Quantitative and qualitative details gathered from the results of experiments are used to guide further design choices meant to either establish the desired activity or test the necessity of our primary sequence selections. This repeated process, termed iterative protein design, has been used to introduce singular structure in either the apo [37] or holo [38] states of the maquettes from molten globular starting sequences and has been instrumental for rapid diversificiation of oxidoreductase activities accessible in the bundles.

The iterative process occurs at two levels. Point mutations, like those used to study natural proteins, are introduced to vary the observed properties of the maquettes, for instance, to convert a bis-histidine metal-porphyrin-binding site into a specific zinc-porphyrin-binding site requires the mutation of a single histidine residue in our most recent maquette variants. A set of these iterations can result in profoundly different oxidoreductase activities, but does not result in a large-scale topological or sequence change (Figure 4, HT1 to HT3). At a higher level, what we term hyper-iteration results in generational changes, where fundamental properties of a prior maquette scaffold are maintained, but protein structural topology or sequence varies significantly (Figure 4, HT1 to HD3 to HM1). The distinction is made because, in all cases, hyper-iterative changes have granted us access to more advanced function often with greater control, which is not possible without a large number of point mutation iterative steps. Unlike evolutionary changes from natural and artificial selection, the iterative design processes are reversible, allowing us to counter the appearance of undesirable activities by continuing our design efforts from an ‘earlier’ iteration.

Figure 4. Diverse functions have been demonstrated in maquettes with minor changes to primary sequence and topology.

Figure 4

Examples of several generations of maquette design, with progression through hydrophilic homotetrameric (HT), hydrophilic homodimeric (HD) and hydrophilic monomeric (HM) four-α-helix bundle sequences, along with their topology (as shown in Figure 1) and various functions. HM2 represents one of the several recent maquettes that branch significantly away in primary sequence from the established soluble maquette family tree. Also included are three amphiphilic homotetrameric (AT) and three helix designs (HZ). AT1 places the hydrophilic helical sequence after an extended hydrophobic sequence, whereas AT2 and AT3 place it before.

Progress

The course from the initial synthetic four-α-helix bundle maquette sequence, a homotetrameric protein, to our current work with expressed single chain monomers is an unbroken series of designed proteins (Figure 4). Representatives of almost all of the redox cofactors found in the oxidoreductases of respiration have been incorporated into this large family of maquettes, although, to date, only ferredoxin-like 4Fe–4S and not Rieske-like 2Fe–2S clusters have been incorporated.

Beyond simply binding cofactors and adopting native structures, advanced oxidoreductase functions have been developed in the maquettes through the iterative design process, including the aforementioned molecular oxygen binding, but also photoreduction and charge separation ([29], and G. Kodali and T.A. Farid, unpublished work). By using engineering principles gleaned from earlier soluble maquette work, we created amphiphilic proteins, which maintained many of the same functions [39]. These amphiphilic maquettes share very little primary sequence identity with the soluble ones and yet demonstrate complex oxidoreductase activities such as molecular oxygen binding and fully realized quinol–cytochrome c oxidoreductase activity reminiscent of the natural activity of the respiratory complex III [34]. Thus progress and understanding of oxidoreductase engineering parameters is not limited to use within only the continuous soluble maquette protein family tree. Indeed, recent efforts in our laboratory have been successful in incorporating haem-binding activity in new maquettes with no intentional sequence homology with previous maquettes or natural proteins for novel catalytic functions. Our ready ability to adjust the exterior residues of our maquettes without sabotaging the interior functions allows us to secure maquettes to each other [40] or to surfaces with electrode properties such as titania [41] and gold [42,43].

Conclusions

What is remarkable about the design process described in the preceding sections is that, despite a great deal of variation in the activities of the maquettes, the sequences of the α-helices have not varied extensively over iterations. This reveals that access to diverse oxidoreductase function in non-natural proteins is readily available using well-established engineering principles gained from observing Nature. Our approach differs from other rational design efforts in the use of non-natural protein scaffolds and the fundamentally iterative nature of our progression. By eliminating the biological complexity imperative with the use of natural protein scaffolds and selecting residue identity with well-established rationales, we are able to explore the fundamental engineering requirements of oxidoreductase activity in simple protein systems. Our continuing efforts are built around the idea that established sequences, which give desired keystone functions, can be combined to fully realize the complex oxidoreductase activities observed in Nature.

Acknowledgments

Funding

The work described in this review that summarizes conceptual and underlying principles of development of maquette redox proteins covering two decades is common to and equally supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [grant number DE-FG02-05ER46223], and the U.S. National Institutes of Health, General Medical Institutes [grant number RO1 GM41048]. This common work underlies individual research aims of each grant.

References

  • 1.Kosiol C, Goldman N. Markovian and non-Markovian protein sequence evolution: aggregated markov process models. J. Mol. Biol. 2011;411:910–923. doi: 10.1016/j.jmb.2011.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Muller HJ. The relation of recombination to mutational advance. Mutat. Res. 1964;1:2–9. doi: 10.1016/0027-5107(64)90047-8. [DOI] [PubMed] [Google Scholar]
  • 3.Darwin C. Origin of Species by Means of Natural Selection. New York: Earlton House; 1872. [Google Scholar]
  • 4.Choi JM, Kang SY, Bae WJ, Jin KS, Ree M, Cho Y. Probing the roles of active site residues in the 3’-5’ exonuclease of the Werner syndrome protein. J. Biol. Chem. 2007;282:9941–9951. doi: 10.1074/jbc.M609657200. [DOI] [PubMed] [Google Scholar]
  • 5.Choi YH, Matsuzaki R, Suzuki S, Tanizawa K. Role of conserved Asn-Tyr-Asp-Tyr sequence in bacterial copper/2,4,5-trihydroxyphenylalanyl quinone-containing histamine oxidase. J. Biol. Chem. 1996;271:22598–22603. doi: 10.1074/jbc.271.37.22598. [DOI] [PubMed] [Google Scholar]
  • 6.Cooperman BS, Baykov AA, Lahti R. Evolutionary conservation of the active-site of soluble inorganic pyrophosphatase. Trends Biochem. Sci. 1992;17:262–266. doi: 10.1016/0968-0004(92)90406-y. [DOI] [PubMed] [Google Scholar]
  • 7.Menon BRK, Davison PA, Hunter CN, Scrutton NS, Heyes DJ. Mutagenesis alters the catalytic mechanism of the light-driven enzyme protochlorophyllide oxidoreductase. J. Biol. Chem. 2010;285:2113–2119. doi: 10.1074/jbc.M109.071522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.O’Farrell HC, Musayev FN, Scarsdale JN, Rife JP. Control of substrate specificity by a single active site residue of the KsgA methyltransferase. Biochemistry. 2012;51:466–474. doi: 10.1021/bi201539j. [DOI] [PubMed] [Google Scholar]
  • 9.Rungsrisuriyachai K, Gadda G. Role of asparagine 510 in the relative timing of substrate bond cleavages in the reaction catalyzed by choline oxidase. Biochemistry. 2010;49:2483–2490. doi: 10.1021/bi901796a. [DOI] [PubMed] [Google Scholar]
  • 10.Azoitei ML, Ban YEA, Julien JP, Bryson S, Schroeter A, Kalyuzhniy O, Porter JR, Adachi Y, Baker D, Pai EF, Schief WR. Computational design of high-affinity epitope scaffolds by backbone grafting of a linear epitope. J. Mol. Biol. 2012;415:175–192. doi: 10.1016/j.jmb.2011.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hedstrom L, Szilagyi L, Rutter WJ. Converting trypsin to chymotrypsin: the role of surface loops. Science. 1992;255:1249–1253. doi: 10.1126/science.1546324. [DOI] [PubMed] [Google Scholar]
  • 12.O’Donoghue P, Sheppard K, Nureki O, Soll D. Rational design of an evolutionary precursor of glutaminyl-tRNA synthetase. Proc. Natl. Acad. Sci. U.SA. 2011;108:20485–20490. doi: 10.1073/pnas.1117294108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Villiers B, Hollfelder F. Directed evolution of a gatekeeper domain in nonribosomal peptide synthesis. Chem. Biol. 2011;18:1290–1299. doi: 10.1016/j.chembiol.2011.06.014. [DOI] [PubMed] [Google Scholar]
  • 14.Yip SHC, Foo JL, Schenk G, Gahan LR, Carr PD, Ollis DL. Directed evolution combined with rational design increases activity of GpdQ toward a non-physiological substrate and alters the oligomeric structure of the enzyme. Protein Eng. Des. Sel. 2011;24:861–872. doi: 10.1093/protein/gzr048. [DOI] [PubMed] [Google Scholar]
  • 15.Jiang L, Althoff EA, Clemente FR, Doyle L, Rothlisberger D, Zanghellini A, Gallaher JL, Betker JL, Tanaka F, Barbas CF, et al. De novo computational design of retro-aldol enzymes. Science. 2008;319:1387–1391. doi: 10.1126/science.1152692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Siegel JB, Zanghellini A, Lovick HM, Kiss G, Lambert AR, Clair JLS, Gallaher JL, Hilvert D, Gelb MH, Stoddard BL, et al. Computational design of an enzyme catalyst for a stereoselective bimolecular Diels–Alder reaction. Science. 2010;329:309–313. doi: 10.1126/science.1190239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Simons KT, Bonneau R, Ruczinski I, Baker D. Ab initio protein structure prediction of CASP III targets using ROSETTA. Proteins Struct. Funct. Genet. 1999;(Suppl. 3):171–176. doi: 10.1002/(sici)1097-0134(1999)37:3+<171::aid-prot21>3.3.co;2-q. [DOI] [PubMed] [Google Scholar]
  • 18.Richter F, Leaver-Fay A, Khare SD, Bjelic S, Baker D. De novo enzyme design using Rosetta3. PLoS ONE. 2011;6:e19230. doi: 10.1371/journal.pone.0019230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Korendovych IV, Kulp DW, Wu YB, Cheng H, Roder H, DeGrado WF. Design of a switchable eliminase. Proc. Natl. Acad. Sci. U.S.A. 2011;108:6823–6827. doi: 10.1073/pnas.1018191108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Sigman JA, Kwok BC, Lu Y. From myoglobin to heme–copper oxidase: design and engineering of a Cu-B center into sperm whale myoglobin. J. Am. Chem. Soc. 2000;122:8192–8196. [Google Scholar]
  • 21.Koder RL, Dutton PL. Intelligent design: the de novo engineering of proteins with specified functions. Dalton Trans. 2006:3045–3051. doi: 10.1039/b514972j. [DOI] [PubMed] [Google Scholar]
  • 22.Regan L, DeGrado WF. Characterization of a helical protein designed from first principles. Science. 1988;241:976–978. doi: 10.1126/science.3043666. [DOI] [PubMed] [Google Scholar]
  • 23.Gibney BR, Rabanal F, Reddy KS, Dutton PL. Effect of four helix bundle topology on heme binding and redox properties. Biochemistry. 1998;37:4635–4643. doi: 10.1021/bi971856s. [DOI] [PubMed] [Google Scholar]
  • 24.Robertson DE, Farid RS, Moser CC, Urbauer JL, Mulholland SE, Pidikiti R, Lear JD, Wand AJ, DeGrado WF, Dutton PL. Design and synthesis of multi-heme proteins. Nature. 1994;368:425–431. doi: 10.1038/368425a0. [DOI] [PubMed] [Google Scholar]
  • 25.Razeghifard AR, Wydrzynski T. Binding of Zn-chlorin to a synthetic four-helix bundle peptide through histidine ligation. Biochemistry. 2003;42:1024–1030. doi: 10.1021/bi026787i. [DOI] [PubMed] [Google Scholar]
  • 26.Gibney BR, Mulholland SE, Rabanal F, Dutton PL. Ferredoxin and ferredoxin-heme maquettes. Proc. Natl. Acad. Sci. U.SA. 1996;93:15041–15046. doi: 10.1073/pnas.93.26.15041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Summa CM, Rosenblatt MM, Hong JK, Lear JD, DeGrado WF. Computational de novo design, and characterization of an A2B2 diiron protein. J. Mol. Biol. 2002;321:923–938. doi: 10.1016/s0022-2836(02)00589-2. [DOI] [PubMed] [Google Scholar]
  • 28.Magistrato A, DeGrado WF, Laio A, Rothlisberger U, VandeVondele J, Klein ML. Characterization of the dizinc analogue of the synthetic diiron protein DF1 using ab initio and hybrid quantum/classical molecular dynamics simulations. J. Phys. Chem. B. 2003;107:4182–4188. [Google Scholar]
  • 29.Sharp RE, Moser CC, Rabanal F, Dutton PL. Design, synthesis, and characterization of a photoactivatable flavocytochrome molecular maquette. Proc. Natl. Acad. Sci. U.S.A. 1998;95:10465–10470. doi: 10.1073/pnas.95.18.10465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lichtenstein BR. A New Approach to Understanding Biological Control of Quinone Electrochemistry. Ph.D. Thesis. Philadelphia, PA, U.S.A: University of Pennsylvania; 2010. [Google Scholar]
  • 31.Li WW, Hellwig P, Ritter M, Haehnel W. De novo design, synthesis, and characterization of quinoproteins. Chem. Eur. J. 2006;12:7236–7245. doi: 10.1002/chem.200501212. [DOI] [PubMed] [Google Scholar]
  • 32.Grosset AM, Gibney BR, Rabanal F, Moser CC, Dutton PL. Proof of principle in a de novo designed protein maquette: an allosterically regulated, charge-activated conformational switch in a tetra-α-helix bundle. Biochemistry. 2001;40:5474–5487. doi: 10.1021/bi002504f. [DOI] [PubMed] [Google Scholar]
  • 33.Koder RL, Anderson JLR, Solomon LA, Reddy KS, Moser CC, Dutton PL. Design and engineering of an O2 transport protein. Nature. 2009;458:305–309. doi: 10.1038/nature07841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hokanson SC. Deconvoluting the Engineering and Assembly Instructions for Complex III Activity. Ph.D. Thesis. Philadelphia, PA, U.S.A.: University of Pennsylvania; 2010. [Google Scholar]
  • 35.Moser CC, Keske JM, Warncke K, Farid RS, Dutton PL. Nature of biological electron transfer. Nature. 1992;355:796–802. doi: 10.1038/355796a0. [DOI] [PubMed] [Google Scholar]
  • 36.Anderson JLR, Koder RL, Moser CC, Dutton PL. Controlling complexity and water penetration in functional de novo protein design. Biochem. Soc. Trans. 2008;36:1106–1111. doi: 10.1042/BST0361106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Huang SS, Gibney BR, Stayrook SE, Dutton PL, Lewis M. X-ray structure of a maquette scaffold. J. Mol. Biol. 2003;326:1219–1225. doi: 10.1016/s0022-2836(02)01441-9. [DOI] [PubMed] [Google Scholar]
  • 38.Koder RL, Valentine KG, Cerda J, Noy D, Smith KM, Wand AJ, Dutton PL. Nativelike structure in designed four α-helix bundles driven by buried polar interactions. J. Am. Chem. Soc. 2006;128:14450–14451. doi: 10.1021/ja064883r. [DOI] [PubMed] [Google Scholar]
  • 39.Discher BM, Koder RL, Moser CC, Dutton PL. Hydrophilic to amphiphilic design in redox protein maquettes. Curr. Opin. Chem. Biol. 2003;7:741–748. doi: 10.1016/j.cbpa.2003.10.013. [DOI] [PubMed] [Google Scholar]
  • 40.Chen XX, Moser CC, Pilloud DL, Gibney BR, Dutton PL. Engineering oriented heme protein maquette monolayers through surface residue charge distribution patterns. J. Phys. Chem. B. 1999;103:9029–9037. [Google Scholar]
  • 41.Topoglidis E, Discher BM, Moser CC, Dutton PL, Durrant JR. Functionalizing nanocrystalline metal oxide electrodes with robust synthetic redox proteins. ChemBioChem. 2003;4:1332–1339. doi: 10.1002/cbic.200300707. [DOI] [PubMed] [Google Scholar]
  • 42.Pilloud DL, Chen XX, Dutton PL, Moser CC. Electrochemistry of self-assembled monolayers of iron protoporphyrin IX attached to modified gold electrodes through thioether linkage. J. Phys. Chem. B. 2000;104:2868–2877. [Google Scholar]
  • 43.Chen XX, Discher BM, Pilloud DL, Gibney BR, Moser CC, Dutton PL. De novo design of a cytochrome b maquette for electron transfer and coupled reactions on electrodes. J. Phys. Chem. B. 2002;106:617–624. [Google Scholar]

RESOURCES